Citation:Non-small Cell Lung Cancer Collaborative Group 1995

Citation

Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311(7010):899-909 Available from: http://www.ncbi.nlm.nih.gov/pubmed/7580546.

Critical appraisals

• Assign a critical appraisal

Cited by

1. Emma.dickins/Sandbox
2. Emma.dickins/Sandbox 2
3. What is the clinical benefit of adjuvant chemotherapy for patients with stage III operable NSCLC?
4. What is the optimal first-line chemotherapy regimen in patients with stage IV inoperable NSCLC?
5. What is the optimal systemic therapy for stage IV inoperable NSCLC?
6. What is the optimal systemic therapy for stage IV inoperable NSCLC?/Historical evolution of systemic drug treatment for stage IV NSCLC
7. What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?
8. What is the role of chemotherapy after surgery in the treatment of operable stage II NSCLC?
9. What is the role of chemotherapy before surgery in the treatment of operable stage II NSCLC?